Analyst upgrades:

• JMP Securities upgraded Vertex Pharma (NASDAQ: VRTX) to Outperform from Market Perform following better-than-expected interim data for telaprevir.
  
• Lazard Capital upgraded shares of Biogen Idec (NASDAQ: BIIB) to Buy from Hold on valuation after their physician survey indicated solid sales growth in the company's MS franchise.
  
• Calyon upgraded Data Domain (NASDAQ: DDUP) to Add from Neutral based on positive channel checks and valuation.
• Goldman added Buckeye GP (NYSE: BGH) to the Conviction Buy List.
  
• Alcatel-Lucent (NYSE: ALU) was upgraded to Hold from Sell and Ericsson (NASDAQ: ERIC) was raised to Hold from Reduce at WestLB.
  
• Keefe Bruyette upgraded Cowen Group (NASDAQ: COWN) to OUtperform from Market Perform.

Analyst downgrades:

• Deutsche Bank downgraded shares of Lloyds TSB Group (NYSE: LYG) to Sell from Hold as they believe loan loss risk will outweigh synergies from the acquisition of HBOS (HBOOY).
  
• Citigroup downgraded shares of National Financial Partners (NYSE: NFP) to Hold from Buy and removed the stock from the Top Picks Live List after the company announced July and August revenues and said pressure continues. The firm lowered their target to $20 from $28.

With a turn of the calendar page, we drift into the middle portion of the current quarter, but the earnings season rolls on. Among the many companies scheduled to report quarterly results this coming week are Time Warner Inc. (NYSE: TWX), Cisco Systems Inc. (NASDAQ: CSCO), News Corp. (NYSE: NWS), and Whole Foods Market International (NASDAQ: WFMI). Let's take a look at which companies Wall Street analysts are expecting to be among the top earnings gainers and decliners this week.

Analysts surveyed by Thomson Financial expect the following to report strong earnings growth when compared to the same period of the previous year.

• DRS Technologies Inc. (NYSE: DRS): $0.85 EPS (+95.3%) on revenue of $823.8 million (+12.0%)
• Integrys Energy Group Inc. (NYSE: TEG): $0.40 EPS (+70.0%) on revenue of $2.6 billion (+9.7%)
• Cimarex Energy Co. (NYSE: XEC): $2.53 EPS (+64.4%) on revenue of $599.9 million (+75.4%)
• Forest Oil Corp. (NYSE: FST): $1.51 EPS (+55.6%) on revenue of $456.1 million (+79.1%)
• Devon Energy Corp. (NYSE: DVN): $3.28 EPS (+48.5%) on revenue of $4.1 billion (+38.5%)
• CMS Energy Corp. (NYSE: CMS): $0.13 EPS (+46.2%) on revenue of $1.4 billion (+6.7%)
• Transocean Inc. (NYSE: RIG): $3.23 EPS (+43.0%) on revenue of $3.1 billion (+112.9%)
• Sara Lee Corp. (NYSE: SLE): $0.26 EPS (+38.5%) on revenue of $3.5 billion (+8.9%)
• Williams Companies Inc. (NYSE: WMB): $0.69 EPS (+37.7%) on revenue of $3.4 billion (+20.0%)
• Harris Corp. (NYSE: HRS): $0.99 EPS (+28.3%) on revenue of $1.4 billion (+18.0%)

MOST NOTEWORTHY: Stanley Works, the Generic Drug sector, Fiserv and Fidelity National were today's noteworthy downgrades:

• Deutsche Bank downgraded shares of Stanley Works (NYSE: SWK) to Hold from Buy as they see risk to Q2 and FY08 earnings due to a slowdown in the European industrial and consumer categories. The firm lowered their target to $52 from $62.
  
• Wachovia cut the Generic Drug sector to Market Weight from Overweight Wachovia sees near-term challenges for Teva Pharmaceutical (NASDAQ: TEVA), Mylan (NYSE: MYL) and Watson Pharmaceuticals (NYSE: WPI). The firm thinks Teva will become a very strong company over the long-term, following its takeover of Barr (NYSE: BRL). However, the firm adds that Teva will need to integrate the acquisition nearly perfectly, and Mylan may feel compelled to make another acquisition, even as it is still integrating Merck Generics, while Watson's growth prospects are still uncertain.
  
• Oppenheimer downgraded Fiserv (NASDAQ: FISV) and Fidelity National (NYSE: FIS) to Perform from Outperform based on multiple pressure from the challenging banking environment and growth headwinds.

OTHER DOWNGRADES:

• Satyam (NYSE: SAY) was downgraded to Underperform from Outperform at Credit Suisse and Equal Weight from Overweight at Morgan Stanley.
  
• UBS downgraded Textron (NYSE: TXT) to Neutral from Buy.
  
• Constellation Energy (NYSE: CEG) was downgraded at Jefferies to Underperform from Hold.

MOST NOTEWORTHY: Drugstore.com, Sycamore and Aflac were today's noteworthy initiations:

• Kaufman Bros. believes Drugstore.com (NASDAQ: DSCM) is well-positioned for long-term growth and significant margin expansion, led by share gains in the OTC and prestige beauty verticals. The firm started shares with a Buy rating and $3.25 target.
  
• Merriman initiated Sycamore (NASDAQ: SCMR) with a Neutral rating and prefers to be on the sidelines given the company's concentrated customer base and lack of clarity on strategic priorities and ongoing business operations.
  
• SunTrust Robinson expects the Aflac's (NYSE: AFL) cancer insurance policies in Japan to benefit from concerns about the national health system. Shares were assumed with a Buy rating and $79 target.

OTHER INITIATIONS:

• Caris initiated Mylan (NYSE: MYL) with a Buy rating and $18 target.
  
• NetSuite (NYSE: N) was assumed with a Hold rating and $22 target at Deutsche Bank.
  
• Stanford initiated Time Warner (NYSE: TWX) with a Buy rating and $20 target.

Mylan Lab (NYSE: MYL), a leading pharmaceutical company, closed at $13.53. Goldman Sachs says, "Upgrading to Buy with $19 price target, we see a bottom in shares." MYL overall option implied volatility of 46 is above its 26-week average of 39 according to Track Data, suggesting larger price movement.

Forest Labs (NYSE: FRX), a U.S.-based pharmaceutical company, closed at $36.71. Cowen says "current pipeline is more valuable than generally perceived, and we believe FRX shares can outperform the market by 15-20% as pipeline viability improves." FRX overall option implied volatility of 44 is above its 26-week average of 37 according to Track Data, suggesting larger price movement.

Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Monday October 29

• VNUS Medical Technologies (NASDAQ: VNUS) patent infringement lawsuit against Angiodynamics (NASDAQ: ANGO), Diomed Holdings (AMEX: DIO), Vascular Solutions (NASDAQ: VASC) begins.
• Verizon Communications (NYSE: VZ) to report Q3 earnings; conference call at 8:30am.

Tuesday October 30

• Sirius Satellite Radio (NASDAQ: SIRI) to report Q3 earnings; conference call at 8am.
• MGM Mirage (NYSE: MGM) to report Q3 earnings; conference call at 11am.
• U.S. Steel Corporation (NYSE: X) to report Q3 earnings; conference call at 2pm.

Wednesday October 31

• Kraft Foods (NYSE: KFT) to report Q3 earnings; conference call at 8am.
• Smith Micro Software (NASDAQ: SMSI) to report Q3 earnings; conference call at 2pm.

Thursday November 1

• PDUFA date for Forest Laboratories (NYSE: FRX) and Mylan Laboratories' (NYSE: MYL) Nebivolol for hypertension.
• Ford Motor Company (NYSE: F) to report October sales at 1pm.
• General Motors Corporation (NYSE: GM) to report October sales at 2pm.

Friday November 2

• PDUFA Date for Sciele Pharma's (NASDAQ: SCRX) Sular formulation
• PDUFA Date for GlaxoSmithKline's (NYSE: GSK) Variza for major depression disorder

MOST NOTEWORTHY: Sanofi-Aventis, Lifecell, Mylan Labs, Panera Bread and Norsk Hydro were today's noteworthy upgrades:

• Societe Generale upgraded shares of Sanofi-Aventis (NYSE: SNY) to Buy from Hold as they believe pipeline maturation over the next 12 months can drive the stock higher.
  
• Piper upgraded shares of Lifecell (NASDAQ: LIFC) to Outperform from Market Perform after their recent survey indicated that AlloDerm remains the leading biologic hernia mesh on the market and competition is making little headway.
  
• JP Morgan upgraded Mylan Labs (NYSE: MYL), Panera Bread (NASDAQ: PNRA) and Norsk Hydro (NYSE: NHY) to Overweight from Neutral. The firm upgraded Mylan based on its position in the global generics market and above-average growth; Panera was upgraded on valuation, as they believe the recent operating risk is now behind the company; Norsk Hydro was upgraded, as they believe the value of the company's aluminum assets are higher than the current share price suggests.

OTHER UPGRADES:

• HSBC upgraded Ride Aid (NYSE: RAD) to Neutral from Underweight.
  
• UBS upgraded Standard Pacific (NYSE: SPF) and Ciena (NASDAQ: CIEN) to Neutral from Sell and Sherwin-Williams (NYSE: SHW) to Buy from Neutral.
  
• Goldman added Cytec Industries (NYSE: CYT) to its Conviction Buy List.

MOST NOTEWORTHY: The U.S. food industry, Mylan Labs, Amerigroup and Isle of Capri were today's noteworthy upgrades:

• BMO Capital upgraded the U.S. food industry sector to Outperform from Market Perform to reflect the group's defensive nature, the recent valuation contraction, and predictable earnings growth. General Mills (NYSE: GIS) is the firm's top pick in packaged food, and they raised Kellogg Company's (NYSE: K) target to $59 and Kraft Foods' (NYSE: KFT) to $36.
  
• Credit Suisse upgraded Mylan Laboratories (NYSE: MYL) to Outperform Underperform, as the firm believes investors are "too negative" on the Merck transaction. The firm said the company is well-positioned long-term to be a leader in the global generics industry.
• Credit Suisse also upgraded shares of Amerigroup Corporation (NYSE: AGP) to Outperform from Underperform, as they believe the company is poised for better than expected margin improvement in 2007 and 2008.
• Isle of Capri Casinos Inc's (NASDAQ: ISLE) rating was upped to Buy from Hold at Morgan Joseph, citing indications of progress in the company's turnaround.

OTHER UPGRADES:

• Epic Bancorp (NASDAQ: EPIK) was upgraded to Buy from Hold at Sandler.
• Aruba Networks Inc (NASDAQ: ARUN) was upgraded to Outperform from Sector Perform at Pacific Crest.
• Lazard upgraded shares of Amylin Pharmaceuticals (NASDAQ: AMLN) to Buy from Hold.
  
• BMO Capital upped shares of Goodrich Petroleum (NYSE: GDP) to Outperform from Market Perform.

MOST NOTEWORTHY: The more noteworthy companies initiated today were ValueClick, Inc (VCLK), Delta Air Lines, Inc (DAL), 24/7 Real Media, Inc (TFSM), Knology, Inc (KNOL) and Allos Therapeutics, Inc (ALTH):

• Banc of America believes ValueClick Inc (NASDAQ: VCLK) is well-positioned for continued strong secular online ad growth and initiated shares with a Buy rating and $35 target.

• Lehman is positive on Delta Air Lines (NYSE: DAL) valuation and earnings growth, starting shares with an Overweight rating and $26.50 target.

• Banc of America believes 24/7 Real Media's (NASDAQ: TFSM) valuation is full at current levels and started shares with a Neutral rating and $12 target.

• RBC believes shares of Knology (NASDAQ: KNOL) are fairly-valued and would wait for a pullback, initiating shares with a Sector Perform rating.

• ThinkEquity started Allos Therapeutics (NASDAQ: ALTH) with a Buy rating and expects significant news flow data on PDX in 2007-2008. In addition, the firm expects to hear an update on enrollment from the PROPEL study, which could be ahead of expectations, and Phase I data in NSCLC in the fall...

OTHER INITIATIONS:

• Goldman resumed coverage with Mylan Laboratories (NYSE: MYL) and Exco Resources, Inc (XCO) with Neutral ratings.

• Merrill Lynch resumed coverage of News Corp (NYSE: NWS) with a Buy rating.

• Lehman started Input/Output, Inc (NYSE: IO) With an Overweight rating and $18 target.

• Needham started Vasco Data Security International, Inc (NASDAQ: VDSI) with a Hold rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Cleveland-Cliffs (NYSE: CLF) -- calls bid up aggressively on heavy volume on buyout chatter. CLF, a producer of iron ore pellets, is recently up $1.75 to $75.30 on unconfirmed take over chatter. CLF has a market cap of $3 billion. CLF is expected to file its 1st quarter 2007 form 10-Q in early June. CLF May 75 calls have traded 105 times on transaction volume of 1,712 contracts above its open interest of 935 contracts. CLF May 75 calls are bid $1.70 above its theoretical value of $1.05. CLF May 80 calls have traded 69 times on transaction volume of 1,818 contracts above its theoretical value of 626 contracts according to Track Data. CLF May 80 calls are bid 45 cents above its theoretical value of 04 cents, suggesting hedging for upside risks.

Mosaic Co. (NYSE: MOS) -- volatility & volume Spikes on buyout Speculation. MOS, a producer & marketer of concentrated phosphate and potash crop nutrients, was spun out of Cargill in 2004. MOS is recently up $1.16 to $30.63. MOS is frequently mentioned as a take out target of Potash Corp. (NYSE: POT). MOS call option volume of 4,791 contracts compares to put volume of 643 contracts. MOS June option implied volatility of 48 is above its 26-week average of 36 according to Track Data, suggesting larger for upside price risks.

Option volume leaders today are: Dendreon Corp. (NASDAQ: DNDN), Advanced Micro Devices (NYSE: AMD), Apple Inc. (NADSAQ: APPL) and Mylan Labs (NYSE: MYL).

Daily Option Update is provided by Stock Options Specialist Paul Foster of theflyonthewall.com.

Stocks may be starting the week flat as futures have been trading in a tight range. Several deals, namely the sale of 80% of the Chrysler Group could help give stocks a push higher, although the busy week in terms of economics data could keep investors in the sidelines.

Last week, stocks finished the week with a big rally on Friday following several economic reports. Weak retail sales and moderating inflation at the wholesale level gave investors hope the Federal Reserve will end up cutting rates.

This week will see more inflation and housing data. While no data is due today, tomorrow CPI, or prices at the consumer level is due. Housing data releases are due later in the week.

No doubt, the biggest story this morning is the sale of 80.1% DaimlerChrysler's (NYSE: DCX) Chrysler Group to a Cerberus, a private equity firm, for $7.4 billion. At the time, in 1998, Daimler-Benz AG bought Chrysler for $36 billion and some still think the deal is a bit expensive for Cerberus. This is the first time private equity holds a major U.S. automaker. DCX shares are up nearly 5% in pre-market trading (7:02 a.m.).

Merck & Co., Inc. (NYSE: MRK) is selling its generic business to Mylan Laboratories Inc. (NYSE: MYL) for $6.6. billion, beating another generic drug maker, Teva Pharmaceuticals Industries Ltd. (NASDAQ: TEVA), out of the deal. MRK shares were up in Frankfurt, MYL shares down over 2.2% in pre-market (7:10 a.m.) and TEVA down 1.6% in pre-market (7:18 a.m.).

Ford family members, founding family of Ford Motor Co. (NYSE: F), are considering the sale of part of their controlling stake in the money-losing automaker. F shares are up 2.3% in pre-market (7:05 a.m.).

Overseas, Japan shares and other Asian markets closed higher, while European stocks are mixed.

The boon of generic pharmaceutical cost efficiency only works when the effectiveness of the generic product matches that of the original. An expert in the art of creating difficult-to-formulate and high-barrier-to-entry generic equivalents is headquartered in Canonsburg, Pennsylvania.

Mylan Laboratories (NYSE:MYL) is one of the world's leading makers of generic drugs, providing 160 products in nearly 400 strengths, covering 46 therapeutic categories. The firm is active in the development and production of sophisticated dosage forms, such as transdermal patches, extended-release tablets and capsules. It is also a leading supplier of unit dose pharmaceuticals to hospitals and other institutions. Customers include wholesalers, distributors, retail drugstore chains and government agencies. Competitors include Teva Pharmaceutical Industries (NASDAQ: TEVA) and Watson Pharmaceuticals (NYSE: WPI).

The stock is up over the past month, on word of various regulatory and legal developments that can benefit the firm. Also, there was word last week that Mylan issued upside guidance for FY07. The company now sees EPS of $1.60-$1.63, versus prior guidance of $1.50-$1.55 and Street consensus of $1.52. MYL shares popped on the news and have since been defining a bullish "flag" consolidation pattern. Prices frequently exit flags moving in the same direction they were traveling when they entered them. In this case, that would be to the upside.

Brokers recommend the issue with two "buys," fourteen "holds" and one "sell." Analysts see a 15% average annual growth rate, through the next five years. The MYL P/E ratio (25.18), PEG ratio (0.90), Price to Cash Flow ratio (12.15), Price to Free Cash Flow ratio (20.98), Sales Growth rate (29.08%), EPS Growth rate (76.00%), Operating Margin (36.38%), Net Profit Margin (23.89%), Return on Assets (17.13%), Return on Investment (19.82%), Return on Equity (37.20%) and Net Income per Employee ($119.39k) compare favorably with industry, sector and S&P 500 averages.

Institutions hold about 65% of the outstanding shares. The stock is one of those used to calculate the S&P 500 Index. Over the past 52 weeks, it has traded between $18.65 and $23.49. A stop-loss of $19 looks good here. Note that the firm is expected to announce fiscal fourth quarter results in mid-May.

Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.

MOST NOTEWORTHY: Chico's FAS, Inc (CHS), Live Nation (LYV) and Clear Channel Communications, Inc (CCU) were some of today's notable upgrades:

• Friedman, Billings, Ramsey upgraded shares of Chico's FAS Inc (NYSE: CHS) to Market Perform from Underperform and raised their target to $25 from $17 on valuation.

• Matrix USA upgraded Live Nation (NYSE: LYV) to Hold from Sell on valuation.

• Sanders Morris upgraded Clear Channel Communications (NYSE: CCU) to Hold from Sell, as the firm believes the disapproval by holders to sell the company will result in shares trading in the $34-$37 range.

OTHER UPGRADES:

• Lehman upgraded PPL Corp (NYSE: PPL) to Overweight from Equal-Weight.

• Friedman, Billings, Ramsey continued to recommend shares of Urban Outfitters, Inc (NASDAQ: URBN) with an Outperform rating as the firm has seen consistent progress at both the company's divisions throughout March. Friedman added Urban Outfitters to its Top Picks list.

• JP Morgan raised Sonic Corp (NASDAQ: SONC) to an Overweight rating from Neutral, and believes shares have priced in softer Q2 sales that were pre-announced late-February.

• Martha Stewart Living Omnimedia, Inc (NYSE: MSO) was upgraded at Bear Stearns to Peer Perform from Underperform.

• Morgan Stanley upgraded Mylan Laboratories (NYSE: MYL) to Neutral from Sell.

• Goldman Sachs upgraded the Mortgage Insurance sector to Neutral from Cautious.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Main market news here.

Apple Inc. (NASDAQ:AAPL) shares are rebounding 0.8% in pre-market trading (7:48 a.m.) after a 5.3% drop yesterday. Following concerns after Apple announced delay of its Apple TV, Tim Cook, Apple's COO reiterated that the company remains on track to release its iPhone mobile-phone product in June, expecting 10 million devices to be sold in 2008.

Dell Inc. (NASDAQ:DELL) shares are up 0.5% in pre-market (7:51 a.m.) after a 3.9% decline yesterday and ahead of its earnings to be reported tomorrow. Analysts, on average, are looking for earnings of 29 cents per share on sales of $14.88 billion, according to a poll by Thomson Financial.

The Walt Disney Company (NYSE:DIS) shares are gaining 1.3% in pre-market (7:41 a.m.) after a 5.7% plunge yesterday. Disney announced it has appointed Anne Gates to the newly created position of executive vice president and managing director of Disney Consumer Products Europe.

DaimlerChrysler AG (NYSE:DCX) is rebounding 2% in pre-market (7:15 a.m.) after losing 4.6% in market value yesterday. The Chrysler Group said yesterday it will offer some of its 49,600 hourly U.S. workers up to $100,000 to leave the company as part of a recovery plan announced earlier this month.

Google Inc. (NASDAQ:GOOG) shares are up 0.7% in pre-market trading (8:04 a.m.) after declining 3.5% yesterday. Forbes is looking at the implication of Monday's ruling allowing Google to refuse any ad.

In all the excitement yesterday it seems that one little story escaped my watchful eye. Prince Charles suggested that banning McDonald's fast food was crucial for improving people's diets. Well, I dare say... Meanwhile, McDonald's Corp. (NYSE:MCD) held up relatively well yesterday, declining 2.9%. This morning in pre-market, MCD shares are flat (7:55 a.m.).

Microsoft Corp.'s (NASDAQ:MSFT) chief software architect Ray Ozzie said that watching Google "was a wake-up call." And how did Microsoft wake up? It now plans to go beyond web-based versions of desktop programs or a one-size-fits-all search. MSFT shares dropped 4.1% yesterday and are up 0.7% in pre-market trading (8:13 a.m.).

Pfizer Inc. (NYSE:PFE) won a suit barring Mylan Laboratories (NYSE:MYL) from marketing the generic version of the popular high blood pressure medication, Norvasc. PFE shares are up 0.9% in pre-market (8:13 a.m.) after closing down 2.7% yesterday.

BusinessWeek.com says that new conditions may ease the planned XM Satellite Radio Holdings Inc. (NASDAQ:XMSR) - Sirius Satellite Radio Inc. (NASDAQ:SIRI) $13.6 billion merger.

The cable division of Time Warner Inc. (NYSE:TWX), Time Warner Cable Inc. said it expects revenue and operating income before depreciation and amortization profit growth in the mid-to-high thirties percentage range in 2007.

Wal-Mart Stores Inc. (NYSE:WMT) will not spin off into separate companies, Tom Schoewe, chief financial officer said.

Sprint Nextel Corp. (NYSE:S) reported a 33% rise in profit to $261 million, or 9 cents a share, with operating revenue up 7% to $10.44 billion. Analysts polled by Thomson Financial expected earnings of 28 cents a share on revenue of $10.39 billion. Sprint shares are up nearly 3% in pre-market trading as of 8:26 a.m.

MAJOR PAPERS:

• According to the Wall Street Journal (subscription required), four months after acquiring YouTube, Google Inc (NASDAQ: GOOG) is struggling to find allies in the television business.
• The Journal's "Heard on the Street" column focused on Mylan Labs (NYSE: MYL), which it said could have "room to run" depending on a key court battle with Pfizer Inc (NYSE: PFE) which it may learn the results of any day.
• According to the online edition of Barron's (subscription required), the Street isn't giving enough credit to GlaxoSmithKline (NYSE: GSK), which has an industry-leading pipeline and profits poised to increase in 2008.
• The Financial Times (subscription required) reported that Wal-Mart Stores (NYSE: WMT) is pressuring its suppliers to better represent women and minorities on the teams that handle Wal-Mart's business.
• The Financial Times also reported that Warner Music Group (NYSE: WMG) has made peace with independent record labels, which could clear the way for the company to make a $6B bid for EMI Corp (OTC: EMIPY).

OTHER PAPERS:

• Investor's Business Daily's "New America" column mentioned Sina Corp (NASDAQ: SINA) positively, saying Sina is the top search engine in China, beating both Google Inc and Yahoo Inc (NASDAQ: YHOO). With e-commerce gaining momentum in the country with a larger population than any other, Sina and analysts have very high hopes for increasing advertising sales in the next two years.